{"notes_translated":{"fr":"Les données de ces rapports de surveillance fournissent de l’information sur les méfaits (décès, hospitalisations et interventions des services médicaux d’urgence) associés aux opioïdes et aux stimulants au Canada.\r\n\r\nL’Agence de la santé publique du Canada (ASPC) travaille en étroite collaboration avec les provinces et les territoires pour recueillir et communiquer des renseignements exacts concernant la crise des surdoses afin de donner un aperçu national de l’impact des opioïdes et autres drogues sur la santé publique au Canada et d’aider à orienter les efforts visant à réduire les méfaits associés aux substances.","en":"Data from surveillance reports provide information on opioid- and stimulant-related harms (deaths, hospitalizations, and responses by emergency medical services) in Canada.\r\n\r\nThe Public Health Agency of Canada (PHAC) works closely with the provinces and territories to collect and share accurate information about the overdose crisis in order to provide a national picture of the public health impact of opioids and other drugs in Canada and to help guide efforts to reduce substance-related harms."},"imso_approval":"true","maintainer":null,"creator":"","association_type":[],"org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"contributor":{"fr":"","en":""},"frequency":"P3M","keywords":{"fr":["opioïdes","opioïde","stimulants","stimulant","cocaïne","méthamphétamine","meth","fentanyl","surdoses","décès","mortalité","hospitalisations","intoxications","intoxication","services médicaux d'urgences","SMU"],"en":["opioids","opioid","stimulants","stimulant","cocaine","methamphetamine","meth","fentanyl","overdoses","deaths","mortality","hospitalizations","poisonings","poisoning","emergency medical services","EMS"]},"data_series_issue_identification":{"fr":"","en":""},"ready_to_publish":"true","id":"1092497d-6c72-4e66-930b-9d6337e64af5","metadata_created":"2019-09-27T14:20:18.188347","subject":["health_and_safety"],"date_modified":"2021-09-16 00:00:00","spatial_representation_type":[],"metadata_modified":"2021-10-12T14:50:49.718725","author":null,"author_email":null,"geographic_region":[],"position_name":{},"portal_release_date":"2019-09-27","digital_object_identifier":"","state":"active","version":null,"relationships_as_object":[],"time_period_coverage_start":"2016-01-01 00:00:00","title_translated":{"fr":"Méfaits associés aux opioïdes et aux stimulants au Canada","en":"Opioid- and Stimulant-related Harms in Canada"},"type":"dataset","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"b4348529-0a4e-470c-8055-2d2816fdc406","state":"active","name_translated":{"fr":"Full Report","en":"Full Report"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Full Report","language":["en"],"created":"2019-12-20T16:32:59.560241","url":"https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/","last_modified":null,"resource_type":"website","position":0,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"2dc5c5c0-e2d6-41ea-a660-aa5369496c1c","state":"active","name_translated":{"fr":"Rapport complet","en":"Rapport complet"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Rapport complet","language":["fr"],"created":"2019-12-20T16:32:59.560248","url":"https://sante-infobase.canada.ca/mefaits-associes-aux-substances/opioides-stimulants/","last_modified":null,"resource_type":"website","position":1,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"48e23022-b7c4-4839-94f4-182019aa060b","state":"active","name_translated":{"fr":"Data","en":"Data"},"hash":"","description":"","format":"CSV","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Data","language":["en"],"created":"2019-12-20T16:32:59.560251","url":"https://health-infobase.canada.ca/src/doc/SubstanceHarmsData.csv","last_modified":null,"resource_type":"dataset","position":2,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"2bccd78b-7066-4b32-8d7c-4097310de2e7","state":"active","name_translated":{"fr":"Données","en":"Données"},"hash":"","description":"","format":"CSV","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Données","language":["fr"],"created":"2019-12-20T16:32:59.560253","url":"https://sante-infobase.canada.ca/src/doc/DonneesMefaitsSubstances.csv","last_modified":null,"resource_type":"dataset","position":3,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"d5afe722-2b02-407b-8962-3ced1d2138f0","state":"active","name_translated":{"fr":"Technical Notes","en":"Technical Notes"},"hash":"","description":"","format":"ZIP","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Technical Notes","language":["en"],"created":"2020-07-13T14:00:53.731049","url":"https://health-infobase.canada.ca/src/doc/SubstanceHarms_TechnicalNotes.zip","last_modified":null,"resource_type":"specification","position":4,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"e8a86dea-64f1-49c2-bf9d-029c3dc81645","state":"active","name_translated":{"fr":"Notes Techniques","en":"Notes Techniques"},"hash":"","description":"","format":"ZIP","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notes Techniques","language":["fr"],"created":"2020-07-13T14:00:53.731059","url":"https://sante-infobase.canada.ca/src/doc/MefaitsSubstances_NotesTechniques.zip","last_modified":null,"resource_type":"specification","position":5,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"1fd9dafb-5514-49da-8034-e32b13d4a0a3","state":"active","name_translated":{"fr":"Archive (Data, Technical Notes, Guide)","en":"Archive (Data, Technical Notes, Guide)"},"hash":"","description":"","format":"ZIP","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Archive (Data, Technical Notes, Guide)","language":["en"],"created":"2020-07-13T14:20:41.435940","url":"https://health-infobase.canada.ca/src/doc/HealthInfobase-SubstanceHarmsData.zip","last_modified":null,"resource_type":"tool","position":6,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"1092497d-6c72-4e66-930b-9d6337e64af5","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"90dab2c6-7f0e-4968-88e6-eae56908332c","state":"active","name_translated":{"fr":"Archive (données, notes techniques, guide)","en":"Archive (données, notes techniques, guide)"},"hash":"","description":"","format":"ZIP","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Archive (données, notes techniques, guide)","language":["fr"],"created":"2020-07-13T14:30:42.102877","url":"https://sante-infobase.canada.ca/src/doc/SanteInfobase-DonneesMefaitsSubstances.zip","last_modified":null,"resource_type":"tool","position":7,"revision_id":"3c9768d8-34a0-4abd-89d1-8155e7733950","data_quality":[]}],"place_of_publication":[],"metadata_contact":{},"num_resources":8,"topic_category":[],"tags":[],"spatial":"","collection":"primary","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2019-12-11 00:00:00","display_flags":[],"groups":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","time_period_coverage_end":"2021-03-31 00:00:00","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"1092497d-6c72-4e66-930b-9d6337e64af5","isopen":false,"license_id":"ca-ogl-lgo","url":null,"notes":"Data from surveillance reports provide information on opioid- and stimulant-related harms (deaths, hospitalizations, and responses by emergency medical services) in Canada.\r\n\r\nThe Public Health Agency of Canada (PHAC) works closely with the provinces and territories to collect and share accurate information about the overdose crisis in order to provide a national picture of the public health impact of opioids and other drugs in Canada and to help guide efforts to reduce substance-related harms.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","audience":[],"license_url":"http://open.canada.ca/en/open-government-licence-canada","program_page_url":{"fr":"https://www.canada.ca/fr/sante-canada/services/dependance-aux-drogues/consommation-problematique-medicaments-ordonnance/opioides/donnees-surveillance-recherche.html","en":"https://www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/data-surveillance-research.html"},"title":"Opioid- and Stimulant-related Harms in Canada","revision_id":"5a396112-75df-4112-9365-5052d151700e"}